Updated on 6 September 2012
Asia is certainly a focus for potential future activity, though after some time. Our strategy in 2012 is to focus on maximizing the success and market penetration of our existing centers in Australia, the UK, The Netherlands, Austria, Germany and Chile, while also commencing sales in a select number of new markets.
What are the future plans of the company?
GI Dynamics is currently focused on the transition from its successful clinical trial experience to broader commercialization of this breakthrough treatment for type 2 diabetes and/or obesity. To achieve this goal, it will: